Rxo [RXO] vs ArcBest [ARCB] Detailed Stock Comparison

Rxo Inc.

NYSE
Loading...

ArcBest Corporation

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Rxo Inc. wins in 6 metrics, ArcBest Corporation wins in 13 metrics, with 0 ties. ArcBest Corporation appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Rxo Inc. ArcBest Corporation Better
P/E Ratio (TTM) 645.33 47.16 ArcBest Corporation
Price-to-Book Ratio 2.04 2.13 Rxo Inc.
Debt-to-Equity Ratio 43.48 35.86 ArcBest Corporation
PEG Ratio 5.16 -0.37 Rxo Inc.
EV/EBITDA 34.81 11.85 ArcBest Corporation
Profit Margin (TTM) -1.74% 1.50% ArcBest Corporation
Operating Margin (TTM) -0.61% 0.42% ArcBest Corporation
EBITDA Margin (TTM) N/A 0.42% N/A
Return on Equity -6.34% 4.61% ArcBest Corporation
Return on Assets (TTM) -0.13% 2.15% ArcBest Corporation
Free Cash Flow (TTM) $-8.00M $100.79M ArcBest Corporation
Dividend Yield N/A 0.60% N/A
1-Year Return 84.69% 154.10% ArcBest Corporation
Price-to-Sales Ratio (TTM) 0.55 0.69 Rxo Inc.
Enterprise Value $3.79B $3.01B Rxo Inc.
EV/Revenue Ratio 0.66 0.75 Rxo Inc.
Gross Profit Margin (TTM) 13.00% 5.09% Rxo Inc.
Revenue per Share (TTM) $34 $176 ArcBest Corporation
Earnings per Share (Diluted) $-0.59 $2.62 ArcBest Corporation
Beta (Stock Volatility) 1.53 1.43 ArcBest Corporation
Short % of Float 24.27% 7.88% ArcBest Corporation

Rxo Inc. vs ArcBest Corporation Stock Performance Analysis

Loading Price Chart...

RXO
ARCB

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Rxo Inc.-2.26%-1.28%48.26%131.69%84.73%115.81%
ArcBest Corporation-5.17%-1.28%33.73%95.06%112.59%112.65%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Rxo Inc.84.69%26.85%31.86%31.86%31.86%31.86%
ArcBest Corporation154.10%96.12%219.56%943.67%687.26%311.12%

Performance & Financial Health Analysis: Rxo Inc. vs ArcBest Corporation

MetricRXOARCB
Market Information
Market Cap i$3.18B$2.73B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i1,942,255253,831
90 Day Avg. Volume i1,877,215289,057
Last Close$27.71$164.10
52 Week Range$10.43 - $29.86$59.43 - $176.69
% from 52W High-7.20%-7.13%
All-Time High$32.82 (Jul 29, 2024)$176.69 (Jun 12, 2026)
% from All-Time High-15.57%-7.13%
Growth Metrics
Quarterly Revenue Growth-0.12%-0.03%
Quarterly Earnings Growth-0.12%-0.03%
Financial Health
Profit Margin (TTM) i-0.02%0.02%
Operating Margin (TTM) i-0.01%0.00%
Return on Equity (TTM) i-0.06%0.05%
Debt to Equity (MRQ) i43.4835.86
Cash & Liquidity
Book Value per Share (MRQ)$9.39$57.98
Cash per Share (MRQ)$0.10$5.57
Operating Cash Flow (TTM) i$51.00M$228.95M
Levered Free Cash Flow (TTM) i$42.75M$79.07M
Dividends
Last 12-Month Dividend Yield iN/A0.60%
Last 12-Month Dividend iN/A$0.60

Valuation & Enterprise Metrics Analysis: Rxo Inc. vs ArcBest Corporation

MetricRXO (Apr 24, 2026)ARCB (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i645.3347.16
Forward P/E i49.1616.63
PEG Ratio i5.16-0.37
Price to Sales (TTM) i0.550.69
Price to Book (MRQ) i2.042.13
Market Capitalization
Market Capitalization i$3.18B$2.73B
Enterprise Value i$3.79B$3.01B
Enterprise Value Metrics
Enterprise to Revenue i0.660.75
Enterprise to EBITDA i34.8111.85
Risk & Other Metrics
Beta i1.531.43
Book Value per Share (MRQ) i$9.39$57.98

Financial Statements Comparison: Rxo Inc. vs ArcBest Corporation

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricRXO (2025)ARCB (2025)
Revenue/Sales i5.74B4.01B
Cost of Goods Sold i4.92B3.73B
COGS % of Revenue i85.6%93.1%
Gross Profit i825.00M275.26M
Gross Margin i14.4%6.9%
Research & Development iN/AN/A
Operating Income (EBIT) i-7.00M99.70M
Operating Margin i-0.1%2.5%
EBITDA i108.00M275.18M
EBITDA Margin i1.9%6.9%
Pre-Tax Income i-115.00M83.10M
Pre-Tax Income % of Revenue i-2.0%2.1%
Income Tax i-15.00M23.00M
Income Tax % of Revenue i-0.3%0.6%
Net Income (Profit) i-100.00M60.10M
Profit Margin i-1.7%1.5%

Balance Sheet & Liquidity Metrics

MetricRXO (2025)ARCB (2025)
Cash & Equivalents i17.00M102.03M
Total Current Assets i1.32B626.06M
Total Current Assets % of Revenue i22.9%15.6%
Total Current Liabilities i1.04B656.89M
Total Current Liabilities % of Revenue i18.1%16.4%
Long-Term Debt i578.00M340.31M
Long-Term Debt % of Revenue i10.1%8.5%
Total Shareholders Equity i1.54B1.30B
Retained Earnings i-384.00M1.48B
Retained Earnings % of Revenue i-6.7%37.0%
Property, Plant & Equipment i238.00M1.42B

Cash Flow Statement Comparison

MetricRXO (2025)ARCB (2025)
Operating Cash Flow i33.00M230.48M
Operating Cash Flow % of Revenue i0.6%5.7%
Capital Expenditures i-57.00M-80.31M
Free Cash Flow i-8.00M100.79M
FCF Margin i-0.1%2.5%
Debt Repayment i-535.00M-108.13M
Common Stock Repurchase i0-75.57M

Short Interest & Institutional Ownership Analysis

MetricRXOARCB
Shares Short i13.95M1.27M
Short Ratio i7.294.19
Short % of Float i24.27%7.88%
Shares Outstanding i164.16M22.35M
Float Shares i125.56M21.95M
% Held by Insiders i0.86%1.38%
% Held by Institutions i107.88%109.75%
% Held by Public i-8.74%-11.13%

Dividend Analysis & Yield Comparison: Rxo Inc. vs ArcBest Corporation

MetricRXOARCB
Last 12-Month Dividend iN/A$0.60
Last 12-Month Dividend Yield iN/A0.60%
3-Year Avg Annual Dividend iN/A$0.52
3-Year Avg Dividend Yield iN/A0.13%
3-Year Total Dividends iN/A$1.56
Ex-Dividend DateN/AFeb 10, 2026